Navigation Links
Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life

DAYTONA BEACH, Fla., Feb. 12 /PRNewswire/ -- CORD:USE Cord Blood Bank is proud to announce that two-time defending NASCAR Sprint Cup Series Champion Jimmie Johnson has joined its team. "We're honored to have this NASCAR superstar and terrific person on our team," states Dr. Edward Guindi, President and CEO of CORD:USE. Jimmie Johnson joins CORD:USE as a spokesperson to participate in its "Help Win the Race for Life(TM)" campaign.

"I'm excited about telling people the benefits of umbilical cord blood donation and cord blood stem cell treatments for people in life-or-death situations," says Johnson.

"The fact that umbilical cord blood, which is normally just thrown out after a baby's born, could be donated and used to save someone's life - that just blows me away. We've got over 75 million good-hearted NASCAR fans out there, and together we can make a real difference in CORD:USE's efforts to save lives. I support this with my whole heart, and you better believe when I'm a parent some day, it's something that I'm going to participate in first hand."

Jimmie Johnson joins other NASCAR greats Rusty Wallace and Michael Waltrip, who have played an active role in increasing public awareness of cord blood donation and the dozens of current applications utilizing cord blood stem cells in transplantation.

"They call it The Race for Life, and it's a race team I'm excited to be a part of. CORD:USE's team is made up of many of the top physicians and scientists in this important medical field, which is saving thousands of lives. You know me, every race I'm in, I want to win - and I'm especially determined to win this one," says Johnson.

Cord blood stem cells have already been used to treat more than 10,000 patients, saving thousands of people who would otherwise not have had a chance of survival. There are currently more than 70 different diseases that have been successfully treated utilizing cord blood stem cells.

About CORD:USE Cord Blood Bank

The CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, has assembled a world-class team of scientists and physicians who are pioneers and world leaders in the fields of cord blood stem cell banking and transplantation. CORD:USE is creating a large, ethnically diverse, high- quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE Cord Blood Bank has entered into agreements with hospitals across the country to provide parents the opportunity to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters, throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit our website .

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
2. Hyperion Therapeutics Secures $40 Million In Series B Round
3. Enobia Pharma Raises $40.1 Million Series B Financing
4. OpGen Announces $23.6 Million Series A Financing
5. Amyris Biotechnologies Announces $70 Million Series B Round
6. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
7. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
8. VisEn Medical Raises $7 Million in Series B Financing
9. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
10. BioVex Closes Second Round of Series E Financing
11. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... SonaCare Medical, LLC, a ... it received de novo clearance from the U.S. Food and Drug Administration (FDA) ... prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device to ...
(Date:10/12/2015)... and BRUSSELS , Oct. 12, 2015 /PRNewswire/ ... today presented additional findings from an exploratory sub-study of the ... were presented today in an oral plenary session at the ... Meeting in Seattle . 2 ... The small exploratory sub-study data showed that, at month ...
(Date:10/12/2015)... Oct. 12, 2015  Rebiotix Inc. today announced ... designated its lead Microbiota Restoration Therapy (MRT) RBX2660 ... recurrent Clostridium difficile (C diff) infection, ... causes 29,000 deaths in the U.S. annually. 1 ... that was founded to revolutionize the treatment of ...
(Date:10/12/2015)... 2015  Patara Pharma, a clinical-stage biotechnology company ... and conditions, today announced the closing of a ... with the close of its sale of preferred ... Security Agreement with Silicon Valley Bank whereby the ... will use the funds from the financing to ...
Breaking Biology Technology:
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, Inc. ... that it has signed a contract with the Virginia ... the full range of sentences under the Department,s oversight. ... the Americas. "This contract with the Virginia DOC will ... US and advances our position as a trusted leader ...
(Date:10/5/2015)... October 5, 2015 ... for NXT-ID, Inc. (NASDAQ: NXTD ), a biometric ... --> ) releases the ... NXTD ), a biometric authentication company focused on ... Technology Group ( ) releases the ...
(Date:10/1/2015)... Oct. 1, 2015  Biometrics includes diverse set ... body characteristics, such as fingerprints, eye retinas, facial ... of biometrics technology has been constantly increasing in ... five years. In addition to the most prominent ... recognition, other means of biometric authentication are rapidly ...
Breaking Biology News(10 mins):